Climb Bio, Inc.
CLYM
$2.33
-$0.15-6.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 84.21% | -1,124.57% | -131.15% | -124.17% | -951.51% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.06% | 173.36% | -3.93% | 17,793.33% | 71,664.38% |
| Change in Net Operating Assets | -252.07% | 714.22% | 17.66% | -117.58% | 174.10% |
| Cash from Operations | -1,571.36% | -748.49% | -483.00% | -316.48% | 91.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 197.26% | -410.89% | -245.34% | -356.05% | -212.30% |
| Cash from Investing | 149.62% | -410.89% | -245.34% | -356.05% | -502.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 1.04% | 330.11% | 534,908.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -85.76% | 330.11% | 534,908.33% |
| Foreign Exchange rate Adjustments | 26.32% | 14.29% | 82.73% | 2,600.00% | -95.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.37% | -588.37% | -264.84% | -340.07% | 1,391.80% |